Cite
APA Citation
Mailankody, S., Salcedo, M., Tavitian, E., Burge, M., Korde, N., Hassoun, H., Lesokhin, A., Lahoud, O., Smith, E., Hultcrantz, M., Tan, C., Shah, U., Devlin, S., & Landgren, O. (2022). ixazomib and dexamethasone in high risk smoldering multiple myeloma: a clinical and correlative pilot study. Leukemia & lymphoma, 63(11), 2760–2761. http://access.bl.uk/ark:/81055/vdc_100169746299.0x000029